Episode 16 - James Fadiman, PhD, and Sophia Korb, PhD - Microdosing!
Listen now
Description
Microdosing: The Phenomenon, Research Results, and Startling Surprises From Psychedelic Science 2017 Yes, Dr. Fadiman is back on the show! I know it seems disproportionate and it is. But after you listen to this episode you'll see why! Microdosing is by far one of the most popular revolutions happening within the psychedelic community today. The wide ranging applications for use in increased cognitive capacity based experiences is fast becoming a legitimate psychedelic method for use within the general population. James Fadiman and Sophia Korb at the center of cyclone with their ongoing research of over 1500 active participants.  From their site,  These are the three most frequently asked questions: How much is a microdose? Most people start at 1/20 to 1/10 of a recreational dose of whatever substance they are trying and adjust based on their experience. If you are experiencing visual effects, you have taken too much. How often are microdoses taken? Most participants dose every three days. Is microdosing right for me? Only you can make that determination. There is more information about who has benefited so far and possible risks in the full FAQ. Over 1500 participants have reported their experiences of microdosing as of this writing, and submitted narrative reports and daily data. We are taking time to read and analyze and report on all the data.  
More Episodes
Episode 74 - Joe Moore, Psychedelics Today Joe Moore, CEO and co-founder of Psychedelics Today, joins this episode of the MAPS podcast for a wide ranging discussion around the past, present and future of psychedelic culture. Joe shares some of his personal story, the origins of Psychedelics...
Published 03/17/24
Published 03/17/24
Episode 73 - Court Wing - Chronic Pain and Psychedelics This episode of the MAPS podcast dives deep into the intersection of chronic pain and psychedelics with Court Wing. If you want to learn something new about an issue that often goes overlooked by the general public, look no further. Chronic...
Published 03/04/24